CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study

Clinical trial NCT04480788 · UNKNOWN

Trial details

NCT number: NCT04480788
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

T Lymphoblastic Leukemia/Lymphoma Extramedullary NK-T-cell Lymphoma, Nasal Type Peripheral T-cell Lymphoma, Nonspecific Angioimmunoblastic T-cell Lymphoma Enteropathy-Associated T-Cell Lymphoma Anaplastic Large Cell Lymphoma, ALK-negative T-cell Lymphoblastic Leukemia

Start date: 2020-11-24
Primary completion: 2022-08-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.